Abstract: Pheochromocytomas and paragangliomas are rare but therapeutically challenging neuroendocrine tumors in urology. Surgical treatment has been recognized as a definitive treatment. However， traditional surgical methods present certain risks and limitations. The rapid development of Da Vinci robotic surgery offers a new approach for treating these tumors. This review elucidate the technical features， clinical applications， treatment outcomes of Da Vinci robotic surgery and the latest research advancements in the treatment of pheochromocytomas and paragangliomas. Additionally, this article discusses the combination of Da Vinci robotic surgery with other emerging technologies, emphasizing the need for further research to validate its long-term efficacy and safety.